VBR (Danke Insights) Files for IPO, Pioneering Data-Driven Innovation in China's Healthcare Sector

VCBeat Research Institute has consistently focused on innovation within the healthcare industry, driven by a dual-engine transformation model. To date, it has published over 400 original reports, covering 81 sub-sectors of medical innovation, and has preliminarily established a global map of the healthcare innovation industry, making it China’s largest provider of original research reports in the health and medical sector.

The core capabilities of VCBeat Eggshell Research Institute are mainly divided into two parts:

First, data and tool capabilities tailored to the broader healthcare industry.VBInsight leverages data technology—characterized by massive-scale collection, granular clarity, and effective structuring—as its foundational technical support, draws on industry research as its core intellectual resource, and delivers its offerings through SaaS database tools and diverse value-added consulting services. It has currently launched the VCBeat Orange Knowledge Base, which primarily encompasses a sector database, a company database, and a report database.

Second, in-depth research capabilities targeting the broader healthcare industry.VCBeat boasts robust data technology and industry research teams, providing in-depth coverage of major sectors within the healthcare industry. These include the pharmaceutical industry (CRO, CDMO, innovative drugs, generic drugs, traditional Chinese medicine, biologics, etc.), the medical device industry (IVD, imaging and large-scale equipment, high-value consumables, low-value consumables, home-use devices and wearables, etc.), the medical services industry (specialty hospitals, consumer healthcare, elderly care, etc.), digital health (internet hospitals, digital therapeutics, pharmaceutical e-commerce, medical AI, chronic disease management, etc.), as well as core industries such as pharmaceutical distribution and retail, and healthcare finance and payment solutions.

By combining these two capabilities, VCBeat Research Institute is committed to empowering enterprise decision-makers, investors, and policymakers with intellectual support, optimizing decision outcomes, driving rapid industry development, and serving as an industry accelerator.

VCBeat’s primary customer base is positioned asStrategic Department, Innovation Department, and Investment Department of Large Enterprises; massive volume in the primary and secondary marketsInvestment InstitutionsandInvestment Research Department of Financial Institutions、Risk Control Department；Government and Relevant Planning, Decision-Making, and Policy-Formulating Departmentsetc.

Government and Industrial Parks:

Shanghai Xuhui District: Implementation Plan for the Medical AI Scenario System;

Xi'an Fengdong New City: Precision Medicine Industry Planning Project;

Chongqing Yuzhong District: 14th Five-Year Plan Projects for the Big Health Industry;

Chengdu High-Tech Zone: Biopharmaceutical-related planned projects;

Hangzhou Xiaoshan District: Biopharmaceutical Industry Planning Project;

National Health Commission: Annual Report on Medical Big Data;

Nanning High-Tech Zone: Compilation of the Panoramic Investment Promotion Map for the Bioindustry;

Zhejiang Shaoxing: Blue Book on the Development of the Medical Device Industry in Shaoxing City;

Chengdu Eastern New Area: Proposal and Planning for the Future Medical City Project;

Hainan Provincial Government: Policy Recommendations for the Development of Digital Health and Digital Therapeutics;

Wuxi Municipal Government: Medical Device Industry Planning Project;

Chongqing Liangjiang New Area: Development Plan and Policy Recommendations for the Pharmaceutical and Biotechnology Industry;

Chongqing Banan District: ITBT Development Plan and Policy Recommendations;

Corporate Clients:

Comprehensively covering large multinational pharmaceutical companies, large multinational medical device companies, large insurance companies, and large state-owned/private enterprises.